Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/17/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/11/2023 |
SC 13D
| Farallon Capital Partners, L.P. reports a 9.9% stake in Chinook Therapeutics, Inc. |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/11/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 08/11/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/11/2023 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 08/11/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 13,300 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/11/2023 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 160,000 options to buy
@ $21.82, valued at
$3.5M
Disposed/sold 40,000 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| Krishnan Mahesh (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 1,275 shares
@ $0
Disposed/sold 26,600 options to buy
@ $16.74, valued at
$445.3k
Disposed/sold 4,401 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| King Andrew James (Chief Scientific Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 19,157 shares
@ $0
Disposed/sold 43,047 options to buy
@ $0.35, valued at
$15.1k
Disposed/sold 73,047 options to buy
@ $0.42, valued at
$30.7k
Disposed/sold 89,545 options to buy
@ $14.77, valued at
$1.3M
Disposed/sold 60,000 options to buy
@ $15.14, valued at
$908.4k
Disposed/sold 21,500 options to buy
@ $17.59, valued at
$378.2k
Disposed/sold 100,000 options to buy
@ $12.9, valued at
$1.3M
Disposed/sold 104,000 options to buy
@ $25.27, valued at
$2.6M
Disposed/sold 10,152 restricted stock units
@ $0
Disposed/sold 6,802 restricted stock units
@ $0
Disposed/sold 16,667 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| GRIFFIN MICHELLE RENEE (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 3,300 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/11/2023 |
4
| Greenman William Mariner (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 23,643 shares
@ $0
Disposed/sold 3,600 options to buy
@ $5, valued at
$18k
Disposed/sold 8,000 options to buy
@ $85, valued at
$680k
Disposed/sold 2,600 options to buy
@ $62.1, valued at
$161.5k
Disposed/sold 2,600 options to buy
@ $52.75, valued at
$137.2k
Disposed/sold 4,000 options to buy
@ $33, valued at
$132k
Disposed/sold 6,000 options to buy
@ $16.45, valued at
$98.7k
Disposed/sold 6,000 options to buy
@ $15, valued at
$90k
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/11/2023 |
4
| Frohlich Tom (COO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 150,777 shares
@ $0
Disposed/sold 43,847 options to buy
@ $0.42, valued at
$18.4k
Disposed/sold 119,793 options to buy
@ $14.77, valued at
$1.8M
Disposed/sold 60,000 options to buy
@ $15.14, valued at
$908.4k
Disposed/sold 30,000 options to buy
@ $17.59, valued at
$527.7k
Disposed/sold 100,000 options to buy
@ $12.9, valued at
$1.3M
Disposed/sold 84,000 options to buy
@ $25.27, valued at
$2.1M
Disposed/sold 13,581 restricted stock units
@ $0
Disposed/sold 6,801 restricted stock units
@ $0
Disposed/sold 16,667 restricted stock units
@ $0
Disposed/sold 21,000 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| DOBMEIER ERIC (President, CEO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 301,138 shares
@ $0
Disposed/sold 353,358 options to buy
@ $0.35, valued at
$123.7k
Disposed/sold 313,555 options to buy
@ $0.42, valued at
$131.7k
Disposed/sold 271,647 options to buy
@ $14.77, valued at
$4M
Disposed/sold 178,600 options to buy
@ $15.14, valued at
$2.7M
Disposed/sold 300,000 options to buy
@ $12.9, valued at
$3.9M
Disposed/sold 255,150 options to buy
@ $25.27, valued at
$6.4M
Disposed/sold 30,797 restricted stock units
@ $0
Disposed/sold 20,248 restricted stock units
@ $0
Disposed/sold 50,001 restricted stock units
@ $0
Disposed/sold 64,050 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| Jerel Davis (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 447,013 shares
@ $0
Disposed/sold 2,105,107 shares
@ $0
Disposed/sold 719,104 shares
@ $0
Disposed/sold 210,996 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/11/2023 |
4
| BJERKHOLT ERIC (CFO) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 39,371 shares
@ $0
Disposed/sold 144,787 options to buy
@ $13.98, valued at
$2M
Disposed/sold 21,501 options to buy
@ $15.14, valued at
$325.5k
Disposed/sold 88,000 options to buy
@ $12.9, valued at
$1.1M
Disposed/sold 84,000 options to buy
@ $25.27, valued at
$2.1M
Disposed/sold 16,415 restricted stock units
@ $0
Disposed/sold 2,435 restricted stock units
@ $0
Disposed/sold 14,667 restricted stock units
@ $0
Disposed/sold 21,000 restricted stock units
@ $0
Disposed/sold 8,400 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| Azelby Robert (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 28,200 options to buy
@ $21.6, valued at
$609.1k
Disposed/sold 7,000 restricted stock units
@ $0 |
|
| 08/11/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 3,300 shares
@ $0
Disposed/sold 5,161,888 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/11/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|